EM2602G "Breaking New Ground in the Science and Practice of Obesity" (IM GR-02.06.26)

Purpose and Overview

Update Internal Medicine faculty and trainees on the transformative impact of the new highly effective incretin hormone-based medications for the treatment of obesity. The presentation will address the societal impact of these medications on multiple stakeholders, the pleiotropic mechanisms of action and clinical outcomes of these agents, and practical tips for clinical management.

Target Audience

UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Discuss the societal impact of the novel incretin hormone-based obesity medications
  • Explain the mechanisms of action and treatment outcomes of incretin hormone-based obesity  medications 
  • Describe practice implications and management of patients receiving incretin hormone-based obesity medications
Course summary
Available credit: 
  • 1.00 AMA
Course opens: 
02/06/2026
Course expires: 
05/06/2026
Cost:
$0.00
Rating: 
0

Dr. Robert Kushner

Robert Kushner, M.D., M.S.
Professor Emeritus
Feinberg School of Medicine
Northwestern University

Available Credit

  • 1.00 AMA

Price

Cost:
$0.00
Please login or create an account to take this course.

Required Hardware/software

Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome